Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Salix Pharmaceuticals patents

Patents where

Current Assignee

Name

‌

Salix Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9192616 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives	Patent 9192616 was granted and assigned to Salix Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.		‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9192616	November 24, 2015
‌ US Patent 9629828 Methods of treating traveler's diarrhea and hepatic encephalopathy	Patent 9629828 was granted and assigned to Salix Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9629828	April 25, 2017
‌ US Patent 11633384 Methods of treating hepatic encephalopathy	Patent 11633384 was granted and assigned to Salix Pharmaceuticals on April, 2023 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	11633384	April 25, 2023
‌ US Patent 9949958 Methods of treating hepatic encephalopathy	Patent 9949958 was granted and assigned to Salix Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9949958	April 24, 2018
‌ US Patent 11311521 Solid dispersion forms of rifaximin	Patent 11311521 was granted and assigned to Salix Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	11311521	April 26, 2022
‌ US Patent 8735419 Forms of rifaximin and uses thereof	Patent 8735419 was granted and assigned to Salix Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.		‌ Salix Pharmaceuticals	United States Patent and Trademark Office	8735419	May 27, 2014
‌ US Patent 8227482 Forms of rifaximin and uses thereof	Patent 8227482 was granted and assigned to Salix Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.		‌ Salix Pharmaceuticals	United States Patent and Trademark Office	8227482	July 24, 2012
‌ US Patent 9700545 Forms of rifaximin and uses thereof	Patent 9700545 was granted and assigned to Salix Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9700545	July 11, 2017
‌ US Patent 9034892 Forms of rifaximin and uses thereof	Patent 9034892 was granted and assigned to Salix Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9034892	May 19, 2015
‌ US Patent 9273066 Forms of rifaximin and uses thereof	Patent 9273066 was granted and assigned to Salix Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9273066	March 1, 2016
‌ US Patent 8642573 Methods of treating hepatic encephalopathy	Patent 8642573 was granted and assigned to Salix Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	8642573	February 4, 2014
‌ US Patent 9421195 Methods of treating hepatic encephalopathy	Patent 9421195 was granted and assigned to Salix Pharmaceuticals on August, 2016 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9421195	August 23, 2016
‌ US Patent 9546183 Forms of rifaximin and uses thereof	Patent 9546183 was granted and assigned to Salix Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9546183	January 17, 2017
‌ US Patent 9855254 Methods of treating hepatic encephalopathy	Patent 9855254 was granted and assigned to Salix Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9855254	January 2, 2018
‌ US Patent 10709694 Methods of treating hepatic encephalopathy		‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	10709694	July 14, 2020
‌ US Patent 10335397 Methods of treating hepatic encephalopathy	Patent 10335397 was granted and assigned to Salix Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	10335397	July 2, 2019
‌ US Patent 8486956 Forms of rifaximin and uses thereof	Patent 8486956 was granted and assigned to Salix Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.		‌ Salix Pharmaceuticals	United States Patent and Trademark Office	8486956	July 16, 2013
‌ US Patent 9737610 Formulations of rifaximin and uses thereof	Patent 9737610 was granted and assigned to Salix Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.		‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9737610	August 22, 2017
‌ US Patent 10493064 IBS microbiota and uses thereof	Patent 10493064 was granted and assigned to Salix Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	10493064	December 3, 2019
‌ US Patent 9931325 Methods for treating irritable bowel syndrome (IBS)	Patent 9931325 was granted and assigned to Salix Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9931325	April 3, 2018
‌ US Patent 8946252 Methods of treating traveler's diarrhea and hepatic encephalopathy	Patent 8946252 was granted and assigned to Salix Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.		‌ Salix Pharmaceuticals	United States Patent and Trademark Office	8946252	February 3, 2015
‌ US Patent 10092573 Gastric and colonic formulations and methods for making and using them	Patent 10092573 was granted and assigned to Salix Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.		‌ Salix Pharmaceuticals	United States Patent and Trademark Office	10092573	October 9, 2018
‌ US Patent 10314828 Methods of treating hepatic encephalopathy	Patent 10314828 was granted and assigned to Salix Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	10314828	June 11, 2019
‌ US Patent 9629829 Methods of treating hepatic encephalopathy	Patent 9629829 was granted and assigned to Salix Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	9629829	April 25, 2017
‌ US Patent 11129817 Solid dispersion forms of rifaximin	Patent 11129817 was granted and assigned to Salix Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	‌ Salix Pharmaceuticals	‌ Salix Pharmaceuticals	United States Patent and Trademark Office	11129817	September 28, 2021

Results per page:

49 results

0 selected

49 results

0 selected